NCEL
NCEL
NASDAQ · Biotechnology

Newcelx Ltd

$2.77
+0.13 (+4.92%)
As of Feb 8, 2:28 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 5.39M 5.45M 4.30M
Net Income -1,299,864 -1,279,500 -760,803
EPS
Profit Margin -24.1% -23.5% -17.7%
Rev Growth -8.0% -5.0% +17.9%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 5.18M 4.90M 4.55M
Total Equity 7.04M 6.89M 6.84M
D/E Ratio 0.74 0.71 0.67
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -1,608,718 -1,854,994 -1,475,925
Free Cash Flow -1,268,218 -1,023,573 -724,682